A Study of SRSD384 in Overweight or Obese Participants

NCT07557355 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight , Obesity

Interventions

DRUG: SRSD384 injection
DRUG: Placebo

Sponsor

Sirius Therapeutics Co., Ltd.